Aimei Health Technology Co., Ltd. is a pioneering healthcare technology firm committed to revolutionizing health solutions through advanced digital platforms and medical devices. With a strong emphasis on improving patient outcomes and streamlining healthcare delivery, the company is a leader in the rapidly expanding telehealth and personalized medicine markets. Leveraging artificial intelligence and data analytics, Aimei enhances operational efficiency within healthcare systems, establishing itself as a vital player in the evolving health tech sector. Its strategic dedication to innovation positions Aimei for substantial growth and influence in driving the future of healthcare.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.04% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | 3.71 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.12M |
| Float | $4.40M |
| % Insiders | 33.60% |
| % Institutions | 19.18% |